Clinical Trials Browser

Recruiting × INDUSTRY × Radiotherapy × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT06667908 2026-06-05

CONVERGE

Phase 2 Recruiting

130 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05765812 2026-05-28

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Phase 1/2 Recruiting

116 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT06116786 2026-05-08

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Recruiting

126 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05124912 2026-02-20

REMASTer: REcurrent Brain Metastases After SRS Trial

Phase NA Recruiting

261 enrolled

CNS

Brain Neoplasms, Neoplasm Metastasis, Recurrence

NCT06459869 2026-02-17

FORTRESS

Phase 1 Recruiting

30 enrolled

Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT03423628 2025-12-22

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Phase 1 Recruiting

180 enrolled

CNS

Brain Neoplasms, Glioblastoma, Inhibition, Psychological, Meningeal Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT06069570 2025-03-05

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Phase 1 Recruiting

48 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Clinical Trials

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

CONVERGE

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

REMASTer: REcurrent Brain Metastases After SRS Trial

FORTRESS

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases